Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU

NCT00925054 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonuria

Interventions

DRUG: rAvPAL-PEG 0.001 mg/kg
DRUG: rAvPAL-PEG 0.003 mg/kg
DRUG: rAvPAL-PEG 0.01 mg/kg
DRUG: rAvPAL-PEG 0.03 mg/kg
DRUG: rAvPAL-PEG 0.1 mg/kg

Sponsor

BioMarin Pharmaceutical